Clinical Trial Update: The Medacta GMK SpheriKA Post-Marketing Surveillance Study

View source ↗

Summary

A post-marketing surveillance study for the GMK SpheriKA knee prosthesis by Medacta International SA is currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthropathy
• Knee Osteoarthritis

Drugs mentioned

• GMK SpheriKA

Snippet

Sponsor: Medacta International SA | Conditions: Arthropathy, Knee Replacement | Status: RECRUITING